Journal of Medicinal Chemistry · 1997 · 95 citations · 25 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyHormonal Cancer TherapyHormonal TherapyOncology PharmacologyAnticancer ActivityAnticancer ChemotherapyCell Growth RegulationCytotoxicity AssaysEstrogen MetabolitesEstrogen PharmacologyEstrogen Receptor SignalingTubulin Polymerization Inhibitors
A new series of estradiol analogs was synthesized in an attempt to improve on the anticancer activity of 2-methoxyestradiol, a naturally occurring mammalian tubulin polymerization inhibitor. The compounds were evaluated as inhibitors of tubulin polymerization and the binding of [3H]colchicine to tubulin, as well as for in vitro cytotoxicity in human cancer cell cultures. Overall, the most potent of the new compounds were 2-(2',2',2'-trifluoroethoxy)-6-oximinoestradiol, 2-ethoxy-6-oximinoestradiol, and 2-ethoxy-6-methoximinoestradiol. These agents lacked significant affinity for the estrogen receptor. The cytotoxicities of the compounds correlated in general with their abilities to inhibit tubulin polymerization, thus supporting inhibition of tubulin polymerization as the primary mechanism causing inhibition of cell growth.
25
Induction of angiogenesis during the transition from hyperplasia to neoplasia
J Folkman, Karol Watson, Donald E. Ingber et al. · Nature · 1989 · 1.9K citations
Medicine, Cell Biology, Oncology +10
Facial shape and judgements of female attractiveness
David I. Perrett, Keith A. May, Sakiko Yoshikawa · Nature · 1994 · 855 citations